Yes. No dilution. Big upfront cash payment. One drug, one disease and one country! AUD$22m and 50/50 JV.
If I knew how much costs would be for production I would have a better idea of what lies ahead. All I know on that is the product is potentially worth billions we would all agree I'm sure. If they can go the distance it will be worth the effort to get 50%. I don't think our JV partner will sting us too much either on production costs as they will be the ones producing it!
Happy for any comments on RGS thread. I'm not pitting one against another just comparing. I didn't particularly like the CR at 65c before the news could be digested by the market. Has stopped any short term run imo.
Ann: Cynata Successfully Completes Capital Raising, page-44
-
- There are more pages in this discussion • 90 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
23.5¢ |
Change
0.005(2.17%) |
Mkt cap ! $42.45M | |||
| Open | High | Low | Value | Volume |
| 23.0¢ | 23.5¢ | 23.0¢ | $7.121K | 30.51K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 40116 | 23.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 14000 | 2 |
View Market Depth
| Last trade - 13.10pm 01/11/2024 (20 minute delay) ? |
| CYP (ASX) Chart |